TVTX

Travere Therapeutics, Inc. is a biopharmaceutical company focused on identifying, developing, and delivering therapies for rare kidney and metabolic diseases. The company has a commercial product for the treatment of IgA nephropathy and a pipeline of investigational therapies. Travere is committed to advancing treatments for patients with high unmet medical needs in rare diseases.